Info_Otros-Programas-Internacionales

OTROS PROGRAMAS INTERNACIONALES Y FUNDACIONES PRIVADAS

**NARSAD - Brain and Behavior Research Foundation**
Resumen	The Brain & Behavior Research Foundation is committed to alleviating the suffering caused by mental illness by awarding grants that will lead to advances and breakthroughs in scientific research.
Objetivo	The focus of this foundation is to understand, prevent, and treat brain and behavioral disorders including autism, anxiety, depression, and others.
Modalidad	There are three funding types as follows: Young Investigator Grants • For investigators at the post-doctoral or assistant professor level. • Two-year awards of US$35.000/year for pilot projects. • Annual call for applications in January-February Independent Investigator Grants • For independent researchers at the associate professor level. • Two-year awards of US$50.000/year. • Annual call for applications in November-December Distinguished Investigator Grants • For the full professor level. • One-year awards of US$100.000 • Annual call for applications in June-July
Link	https://bbrfoundation.org/grants

**European Molecular Biology Organisation (EMBO)**
Resumen	EMBO is an organization that promotes excellence in life science careers, with an emphasis on molecular biology.
Objetivo	EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and EMBO Press publications disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science policy by seeking input and feedback from our community and by following closely the trends in science in Europe.
Modalidad	It provides support through the following mechanisms: Short-Term and Long-Term, and European Respiratory Society (ERS) Fellowships • Intended for postdoctoral-level researchers • Funding to return to a home lab (short-term), to work abroad (long-term), or to recruit more respiratory clinicians into research (ERS) • Application deadlines: Ongoing (short-term); annually, February 12 and August 12 (long-term); and annually, January, April, and October (ERS) Young Investigators: • For the assistant professor level • Funding of 15.000€ and an extensive network of opportunities for mentoring and professional development. • Annual application deadline, April 1 Travel and Lecture Grants • Funding to attend or organize EMBO events
Link	http://www.embo.org/funding-awards

**U.S. National Institutes of Health (NIH)**
Resumen	The U.S. National Institutes of Health fund a wide variety of biomedical projects in fields such as cancer biology, vaccine development, mental health biology, drug and alcohol addiction treatments, bioinformatics, and many more, with new opportunities announced weekly.
Objetivo	Non-U.S.-based research groups must either provide evidence that they can contribute a unique resource that is not available in the U.S. (e.g., a unique collection of samples) OR they may act as the sub-contractor of a U.S.-based collaborator.
Modalidad	NIH offers funding for many types of grants, contracts, and programs.
Link	https://grants.nih.gov/grants/guide/index.html

**Worldwide Cancer Research**
Resumen	Translational cancer research
Objetivo	This foundation provides financing for projects that could reduce the incidence of cancer or improve cancer survival.
Modalidad	Projects of 12-36 months will be funded for up to 250.000 £. Applications are due annually in April or October.
Link	http://www.worldwidecancerresearch.org/funding/make-an-application

Más información: proyectoseuropeos@ehu.eus

Proyectos de Ciencias de la Vida

Vacunas que replican estructuras con capacidad de neutralización dentro de la región externa proximal de la membrana de HIV1-gp41

NIH-CIH project

Programa específico: Institutos Nacionales de Salud de EE. UU. y los Institutos Canadienses de Investigación en Salud
UPV/EHU: Socio del consorcio
Supervisor de la UPV/EHU: Jose Luis Nieva Escandon
Inicio del proyecto: 01/10/2011
Fin del proyecto: 28/02/2018

Breve descripción: El objetivo es producir una vacuna líder para todos los tipos de infección por VIH-1 y, como tal, es relevante para todas las poblaciones clave a las que se dirige la Iniciativa de Investigación sobre VIH/SIDA de los CIHR. Los investigadores buscan producir una vacuna que imite la estructura de la región externa proximal a la membrana de gp41 (MPER) tal como existe en el virus; imitando la estructura de neutralización competente de la MPER, con la expectativa de producir una vacuna que genere anticuerpos que se unirán a la MPER en el virus y evitarán que infecte con éxito las células.